References
Sackett DL. Clinical epidemiology. What, who, and whither. J Clin Epidemiol. 2002;55:1161–6.
Guyatt GH, Haynes RB, Jaeschke RZ, et al. Users’ guides to the medical literature: XXV. Evidence-based medicine: principles for applying the users’ guides to patient care. Evidence-based medicine working group. JAMA. 2000;284:1290–6.
Moll AC, Imhof SM, Cruysberg JR, et al. Incidence of retinoblastoma in children born after in-vitro fertilisation. Lancet. 2003;361:309–10.
Singh AD, De Potter P, Fijal BA, et al. Lifetime prevalence of uveal melanoma in white patients with oculo(dermal) melanocytosis. Ophthalmology. 1998;105:195–8.
Moll AC, Imhof SM, Bouter LM, et al. Second primary tumors in patients with hereditary retinoblastoma: a register-based follow-up study, 1945–1994. Int J Cancer. 1996;67:515–9.
U.S. Department of Health and Human Services. Principles of epidemiology in public health practice: An introduction to applied epidemiology and biostatistics. Atlanta, GA: Centers for Disease Control and Prevention (CDC). Office of Workforce and Career Development; 2006. p. 30333.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–81.
Cohn JN. Introduction to surrogate markers. Circulation. 2004;109(25):IV-20-IV-21.
Foss AJ, Lamping DL, Schroter S, et al. Development and validation of a patient based measure of outcome in ocular melanoma. Br J Ophthalmol. 2000;84:347–51.
Moll AC, Imhof SM, Kuik DJ, et al. High parental age is associated with sporadic hereditary retinoblastoma: the Dutch retinoblastoma register 1862–1994. Hum Genet. 1996;98:109–12.
Fletcher O, Easton D, Anderson K, et al. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst. 2004;96:357–63.
Moll AC, Imhof SM, Schouten-van Meeteren AYN, et al. Screening for pineoblastoma in patients with retinoblastoma. Arch Ophthalmol. 2001;120:1774.
Harbour JW. What is the best treatment for retinoblastoma? Am J Ophthalmol. 2004;138:471–3.
Harbour JW, Brantley MA Jr, Hollingsworth H, et al. Association between choroidal pigmentation and posterior uveal melanoma in a white population. Br J Ophthalmol. 2004;88:39–43.
Abel U, Koch A. The role of randomization in clinical studies: myths and beliefs. J Clin Epidemiol. 1999;52:487–97.
Oxman AD, Guyatt GH. A consumer’s guide to subgroup analyses. Ann Intern Med. 1992;116:78–84.
Lasky T, Stolley PD. Selection of cases and controls. Epidemiol Rev. 1994;16:6–17.
Friedman LM, Furberg CD, De Mets DL. Fundamentals of clinical trials. St Louis: Mosby; 1996.
Seregard S. Long-term survival after ruthenium plaque radiotherapy for uveal melanoma. A meta-analysis of studies including 1,066 patients. Acta Ophthalmol Scand. 1999;77:414–7.
Yu G, Zhou X, Li J. A meta-analysis of the efficacy of intra- arterial chemotherapy for the management of retinoblastoma patients. Adv Clin Exp Med. 2023;33:207. https://doi.org/10.17219/ acem/166664.
Further Reading
Bouter LM, Zielhuis GA, Zeegers MP. Textbook of epidemiology. Houten: Bohn Stafleu van Loghum; 2018.
Fletcher RH, Fletcher SW, Wagner EH. Clinical epidemiology: the essentials. Baltimore: Williams & Wilkins; 1996.
Guyatt G, Rennie D, editors. Users’ guide to the medical literature: a manual for evidence-based clinical practice. Chicago: AMA Press; 2002.
Rothman KJ. Epidemiology: an introduction. New York: Oxford University Press; 2002.
Sackett DL, Strauss SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-based medicine. Edinburgh: Churchill Livingstone; 2000.
User’s guide to evidence-based practice. Educative series of articles from the JAMA. www.cche.net/usersguides/main.asp.
Website of the centre for evidence-based medicine, Oxford, United Kingdom. www.cebm.net.
Дальше — с подпиской Awamed+
Осталось ещё 300 страниц источника. Подписка открывает материал целиком вместе с оригиналом, рисунками и файлами.